Clinical TrialsSearch results
Number of results: 318
Other
- A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride/ sodium ferrous citrate (5-ALA-HCl/ SFC) for patients with adult-onset still's disease (AOSD) refractory to corticosteroids
- Adult Onset Still's Disease
- Kawakami Atsushi
- 2023-01-07
Other
- Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX SIRIUS STUDY I (the IFX-SIRIUS STUDY II): Study protocol for an interventional, multicenter ,open label, single arm clinical trial with clinical, ultrasound and biomarker assessments
- Rheumatoid arthritis
- Kawakami Atsushi
- 2020-04-20
Other
- Long-term Safety and Efficacy of Filgotinib in Patients with Idiopathic Multicentric Castleman's Disease (iMCD)
- idiopathic multicentric Castleman's disease
- Kawakami Atsushi
- 2024-03-04
Other
- Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): Study protocol for an interventional, multicenter, open-label, single-arm and noninferiority clinical trial with clinical, ultrasound and biomarker assessments
- Rheumatoid arthritis
- Kawakami Atsushi
- 2019-10-11
Recruiting
- Analysis of effectiveness of Ozoralizumab toward bone structure in rheumatoid arthritis
- Rheumatoid arthritis
- Kawakami Atsushi
- 2023-09-27
Recruiting
- Discontinuation of methotrexate in rheumatoid arthritis patients achieving clinical remission by treatment with upadacitinib plus methotrexate (DOPPLER study): Study protocol for an interventional, multicenter, open-label and single-arm clinical trial with clinical, ultrasound and biomarker assessments
- Rheumatoid arthritis
- Kawakami Atsushi
- 2021-01-12
Recruiting
- Investigator-Initiated Study of Filgotinib in Patients with Idiopathic Multicentric Castleman Disease (iMCD)
- idiopathic multicentric Castleman's disease
- Kawakami Atsushi
- 2024-01-22
No Longer Recruiting
- Efficacy and safety of selective JAK 1 inhibitor Filgotinib in active rheumatoid arthritis patients with inadequate response to conventional synthetic disease-modifying antirheumatic drugs: Comparative study with Filgotinib and interleukin 6 inhibitor examined by clinical index as well as musculoskeletal ultrasound assessment(TRANSFORM study): Study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial
- Rheumatoid arthritis
- Kawakami Atsushi
- 2021-03-03
Completed
- Effectiveness of Etanercept Biosimilar Initiating for Etanercept -Naive Patients, using Ultrasound, Clinical and Biomarker Assessments in Outcomes of Real World Therapy(ENPORT-NGSK Study):Study protocol for an interventional, multicenter, open-label, single-arm clinical trial
- Rheumatoid arthritis
- Kawakami Atsushi
- 2020-11-18
Completed
- Efficacy of Etanercept Biosimilar Switching from Etanercept Reference Product, using Ultrasound and Clinical Data in Outcomes of Real World Therapy (ESCORT-NGSK Study):Study protocol for an interventional, multicenter, open-label, single-arm clinical trial
- Rheumatoid arthritis
- Kawakami Atsushi
- 2020-02-20